MENU × BUSINESS
Banking And InsuranceCryptocurrencyDigital MarketingErpFood And BeveragesHealthcareLegalMarketing And AdvertisingMedia And EntertainmentMetals And MiningOil And GasRetailTelecom
TECHNOLOGY
Artificial IntelligenceBig DataCloudCyber SecurityE CommerceEducationGaming And VfxIT ServiceMobileNetworkingSAPScience And TechnologySecuritySoftwareStorage
PLATFORM
CiscoDatabaseGoogleIBMJuniperM2MMicrosoftOracleOracleRed Hat
LEADERSHIP
CEO ReviewCompany Review
MAGAZINE
ASIA INDIA
STARTUPS CLIENT SPEAK CONTACT US

The Silicon Review Asia

Madras High Court’s ruling temporarily bans the sale of online medicines

Madras High Court’s ruling temporarily bans the sale of online medicines

Madras High Court has passed an interim order that restrains online e-pharmacies from selling medicines online until further orders, thus affecting the clash between the traditional drug stores and online stores. This move comes after a plea from the Tamil Nadu Chemists and Druggists Association regarding the authenticity and safety of the medicines being sold online. The association has requested to block the links of websites saying that their products might be expired, unapproved and fake.

It has also emphasized on the Drugs and Cosmetics Act, 1940, and Drugs, Cosmetics Rules, 1945 and Pharmacy Act, 1948 pointing out that the online sale of medicines in India is not legalised.For now, the Centre will have to respond on the case according to the court’s ruling, and the further hearing will be done on November 9.

Pradeep Dadha, Netmeds.com founder and CEO, said, “We came to know from the media that some order was passed by the Honourable Madras High Court and we would not be in a position to comment on this till our legal team examines the implications of the ruling.” Over the past two years, several traditional medical stores have been making their protests against the expansion of online pharmacy stores in India under the banner of AIOCD (All India organization of chemists and druggists).

The Drug Controller General of India (DGCI) has thus formed a panel of seven members to investigate the issue of online medicine sales and had proposed for a developing a license for the pharmacies. Some guidelines have also been sanctioned according to which e-pharmacies have to pay a fee of Rs 50,000 for registration with the DCGI which will be valid for three years and they won’t be allowed to sell tranquilisers, narcotic drugs and Schedule X drugs.

YOU MAY ALSO LIKE

Marketing Partnership: NBA, McDonald’s Will Jointly open NBA Experience Zones India

There is good news for all basketball fans in India. Very soon, NBA themed promotions and experience zones will be launched in India. The announcement...

Dunzo to Raise Funds from Google, others

Dunzo, the app which is trying to make life easier for the people upto some extent plans to raise about Rs. 183 crore from different investors which a...

Sapta Shakti Command Will Be Displaying Defence Technology Equipment at Jaipur Military Station

This event is organised with an aim to provide an opportunity where one and all can experience the developments in the field of defence and security-r...

Samsung is All Set to Roll out Its Galaxy A9 Smartphone On November 20

After Samsung unveiled its new Galaxy A9 smartphone in Singapore last month, the company is all set to launch it in India on November 20. In Singapore...

RECOMMENDED